Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer.
about
ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancersThe etiologic spectrum of head and neck squamous cell carcinoma in young patientsHPV Positive Head and Neck Cancers: Molecular Pathogenesis and Evolving Treatment StrategiesIs radiation dose reduction the right answer for HPV-positive head and neck cancer?Warburg effect, hexokinase-II, and radioresistance of laryngeal carcinomaMolecular Aspects of Head and Neck Cancer TherapyModulation of therapeutic sensitivity by human papillomavirusTumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancerManagement of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis.Prognostic significance of LINE-1 hypomethylation in oropharyngeal squamous cell carcinoma.Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy (Review).Head and neck cancer stem cells: the effect of HPV--an in vitro and mouse studyBiological Features of Human Papillomavirus-related Head and Neck Cancers Contributing to Improved Response.Clinical and scientific impact of human papillomavirus on head and neck cancer.Regulation of HPV16 E6 and MCL1 by SF3B1 inhibitor in head and neck cancer cells.Synergistic anti-cancer effect of phenformin and oxamate.Impact of HPV in Oropharyngeal Cancer.Circulating CD4-positive lymphocyte levels as predictor of response to induction chemotherapy in patients with advanced laryngeal cancerAerobic cervical bacteriology and antibiotic sensitivity patterns in patients with advanced cervical cancer before and after radiotherapy at a national referral hospital in Uganda.Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma.The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas.CD137 enhancement of HPV positive head and neck squamous cell carcinoma tumor clearance.Oropharyngeal cancer epidemic and human papillomavirus.Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancer.Stereotactic body radiotherapy for recurrent oropharyngeal cancer - influence of HPV status and smoking history.Infiltrating lymphocytes and human papillomavirus-16--associated oropharyngeal cancer.CD200: association with cancer stem cell features and response to chemoradiation in head and neck squamous cell carcinoma.STAT1 Activation Is Enhanced by Cisplatin and Variably Affected by EGFR Inhibition in HNSCC CellsSickness behavior induced by cisplatin chemotherapy and radiotherapy in a murine head and neck cancer model is associated with altered mitochondrial gene expressionPrognostic value of some tumor markers in unresectable stage IV oropharyngeal carcinoma patients treated with concomitant radiochemotherapy.De-escalation of radiation dose for human papillomavirus-positive oropharyngeal head and neck squamous cell carcinoma: A case report and preclinical and clinical literature review.Definitive radiation therapy without chemotherapy for human papillomavirus-positive head and neck cancer.A non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumors.Development and characterization of HPV-positive and HPV-negative head and neck squamous cell carcinoma tumorgrafts.Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFNγ That Induce PD-L1 Expression in Head and Neck Cancer.EBV and not HPV sensitizes tobacco-associated head and neck cancer cell line FaDu to radiotherapy.Improved clearance during treatment of HPV-positive head and neck cancer through mTOR inhibition.Molecular characterization of head and neck cancer: how close to personalized targeted therapy?Biology of human papillomavirus-related oropharyngeal cancer.
P2860
Q24303562-01951995-78AB-4C37-A608-35C35DD5EA2DQ26741362-9A4B959D-E5D8-40EE-985D-003B53CF5C3DQ26752584-4B72F37A-7CF7-472A-9CDC-E3E32954130CQ27024764-AC314425-4D71-4F2A-9E8B-4DEAED5BFE69Q28072714-0E4798EC-792F-4E1A-BA00-1D2BA2D8648FQ28082815-7030BDB3-9A3C-4401-9F23-E57827255FF0Q28087031-94A15717-08B5-4B3B-9E84-5D2624C71583Q28728574-004A0E84-0514-41D6-A88C-9407C2751766Q30252081-1D40A69B-EAD5-4F98-A8E4-1196CA6BA2AEQ30650708-0F334903-A25F-424B-9409-DC71C213D6B9Q33742722-E18E04BB-49D1-4C78-8AFE-93200C3BFB20Q33778119-B83BAAD8-489C-4015-AAFC-65CABDA256FFQ33863903-424958F9-97EA-44D2-9FB0-0CA6F6545453Q33908290-B3E087F3-6096-42D6-842F-8D6E8C96F685Q34031281-53847554-1240-4636-B10D-C3E108860FB7Q34068144-CB9B032C-2B1C-4424-A43D-686892EED573Q34400208-6460588C-171A-42AD-884A-B8D63090F5C4Q34479115-D974C412-0A9F-4780-89B7-156CD6CAAF0FQ34569283-C0348B60-B70E-474C-A136-F3116144C974Q35160789-3912C2A3-9821-401C-9E71-83BF152F4758Q35201899-DF1F8246-01CF-4E58-BB88-E7F7A2A2A85CQ35344832-7BCAFB2D-50E4-4852-ADC1-B978480BEF66Q35600651-4978532D-D842-41E9-AFBA-04438754E733Q35804927-D7FC6A17-D888-43B0-85C5-1565D5DBD112Q35837683-52C96232-1BF2-4EC5-9104-D470B023CC02Q35861606-8D17B561-1208-4A3A-B1FB-151D7C8831F2Q35913813-60E7D7E5-1276-4596-A448-31AA73E0389AQ36019782-91014F6A-46D2-483D-920D-9426CCDB1FD3Q36030906-8B37CA97-6198-4EB2-889C-D0A31185EC6CQ36373009-F7E5C8E7-C5AA-4594-9DBB-F41953B9E624Q36490386-2DDBFBCA-54EA-493B-9ED1-BAABD5386663Q36502676-CF1937A9-BFFA-4C86-BCC7-B9DA4D39CFE4Q36590501-23251DCB-10F4-47D7-817F-42B1AC2D6985Q36607578-2F005C8A-EF39-4FBF-8108-6D7DF52E4B67Q36637164-8C99653D-D0BB-47DF-9829-77C94A4A13C5Q36642668-C1285702-C125-4530-A009-5AADB0169541Q36772369-94FFCFD8-96B6-46F6-8848-CF061D223DF2Q36879225-31948BFB-CD6C-474A-85B2-190D57D7B3E0Q37000422-88B0D860-410C-4F1D-A682-9ED46F2F7862Q37023708-36660AEC-1D98-4CFF-8C89-E034C839D298
P2860
Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Immune response during therapy ...... -related head and neck cancer.
@en
Immune response during therapy ...... -related head and neck cancer.
@nl
type
label
Immune response during therapy ...... -related head and neck cancer.
@en
Immune response during therapy ...... -related head and neck cancer.
@nl
prefLabel
Immune response during therapy ...... -related head and neck cancer.
@en
Immune response during therapy ...... -related head and neck cancer.
@nl
P2093
P356
P1433
P1476
Immune response during therapy ...... -related head and neck cancer.
@en
P2093
Andrew Hoover
Anjali Gupta
Bruce Hostager
Dong Wook Lee
John H Lee
Mary E Anderson
Paul Nowicki
William C Spanos
P304
P356
10.1001/ARCHOTO.2009.159
P577
2009-11-01T00:00:00Z